Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients

Measurement of Colchicine Levels in the Serum of FMF Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03210610

Enrollment

Registered

2017-07-07

Start date

2017-10-19

Completion date

2020-07-15

Last updated

2018-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colchicine Resistance, Colchicine Toxicity, FMF

Brief summary

in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine

Detailed description

80 FMF patients will enroll: 20 taking 1 mg colchicine a day 20 taking 1.5 mg colchicine a day 20 taking 2 mg colchicine a day 20 taking 2.5 mg colchicine a day one blood sample for trough colchicine levels will be taken. response to treatment, colchicine side effects and anthropometric data will be collected.

Interventions

DIAGNOSTIC_TESTcolchicine level measurement

levels of colchicine will be measured in FMF patients taking colchicine

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* constant colchicine levels

Design outcomes

Primary

Measure	Time frame	Description
colchicine levels	a single measurement under a constant dosage at visit 1 (time=0, recruitment)	the trough level of colchicine in the serum

Countries

Israel

Contacts

Primary Contactmerav lidar, prof

merav.lidar@sheba.health.gov.il+972-3-5304413

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026